InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Monday, 09/26/2016 12:36:36 PM

Monday, September 26, 2016 12:36:36 PM

Post# of 3140
ONTX EDISON issued a conservative valuation of $171m back in 2015 mentioned rigosertib potential and the company just did more step forward. cap is under 20m (vs 27.6m cash on hand). http://www.edisoninvestmentresearch.com/research/report/onconova-therapeutics8

Onconova Announces Successful End-of-Phase 2 Meeting with FDA for Oral Rigosertib and Azacitidine Combination
GlobeNewswire•September 26, 2016 http://finance.yahoo.com/news/onconova-announces-successful-end-phase-110100219.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM5MjBlaWZsYnVpNWluBGcDZFhWcFpEeHVjejVqWVRFeE5Ua3pZUzA1TWpNd0xUTXpNVE10WWpRd05pMDNObVJoTmpaaE16TmtNek04Wm1sbGJHUStiMjUwZUE9PQRsYW5nA2VuLVVTBG9yaWdfbGFuZwNlbgRvcmlnX3JlZ2lvbgNVUwRwb3MDMARyZWdpb24DVVMEc3ltYm9sA09OVFg-?soc_src=social-sh&soc_trk=tw

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONTX News